Molecular Biomedicine and Biotechnological Drugs Working Group

The Molecular Biomedicine and Biotechnological Medicines Working Group focuses on studies aimed at improving the field of Medicine and Modern Medicine in Turkey during the transformation process of health, which is a critical element of competitiveness in the global economy. It is aimed to carry out the necessary experimental and clinical studies to ensure the technological transformation that will enable the production of high value-added pharmaceuticals and healthcare in our country and to successfully realize the healthcare transformation in the Turkish industry. In this context, the Molecular Biomedicine and Biotechnological Medicines Working Group establishes close collaborations with public institutions, sectoral organizations, health research centers, international stakeholders and various universities.